More specific treatment strategies in bronchiectasis depend on the underlying etiology and include protein augmentation (alpha 1-antitrypsin deficiency), anti-allergic approaches (asthma/ABPA) and/or immunoglobulin substitution (immunodeficiencies). Here, PSMA6 is linked to immune system disorder.